Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptome analysis of 125 ESCC samples

ABSTRACT: In order to explore the clinical significance of several key genes, an Affymetrix IVT microarray of 125 ESCC patients were used to find the potential prognostic factors

ORGANISM(S): Homo sapiens

PROVIDER: GSE121931 | GEO | 2019/12/20

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Transcriptome analysis of 125 ESCC samples

Project description:Transcriptome analysis of 125 ESCC samples

| PRJNA499093 | ENA

Differential protein expression between ESCC and normal tissues

Project description:To understand the difference of protein expression between paired esophageal squamous cell carcinoma (ESCC) and adjacent normal tissues, we collected 10 paired ESCC and normal tissues from surgical resected specimems for high-throughput proteomic experiments. From comparative analysis, the dysregulated signaling pathways in ESCC could be uncovered.

2020-08-11 | PXD019834 | Pride

The dataset to discover ESCC related proteins

Project description:To discover ESCC related proteins, we used SWATH to quantify the protein abundance between ESCC and adjacent tissues. Briefly, we pooled 10 ESCCtissues and their corresponding adjacent tissues for SWATH acquisition with three replicates.Three DDA repeats were also acquired with the pooled 10-paired ESCC tissue.The trypsin digested peptide mixture was analyzed by AB SCIEX 5600 (AB SCIEX).The database searching procedure was achieved using ProteinPilot v4.5 (AB Sciex). The database is IPI_homo_sapiens_V3.87.

2015-09-22 | PXD001764 | Pride

SNP data from 125 hepatocellular carcinomas and 112 paired normal samples

Project description:SNP array data from 125 hepatocellular carcinomas were used to detect recurrent copy number alterations.

2012-02-27 | GSE32649 | GEO

microRNA expression data of tumor tissues and paired pericarcinomatous tissue of 15 ESCC samples

Project description:We detected the expression of miRNA in 15 ESCC samples' tumor tissues and the corresponding normal esophagus tissue. Then, we identified the differentially expressed miRNAs in ESCC.

2021-10-28 | GSE131453 | GEO

microRNA expression data of a paired fibrosarcoma with ESCC samples

Project description:We detected the expression of miRNA in a fibrosarcoma with ESCC sample and the corresponding normal esophagus tissue. Then, we identified the differentially expressed miRNAs in this rare disease.

2018-03-20 | GSE112030 | GEO

Global gene expression profiling and validation in esophageal squamous cell carcinoma (ESCC)

Project description:Esophageal squamous cell carcinoma (ESCC) is an aggressive tumor with poor prognosis. Understanding molecular changes in ESCC should improve identification of risk factors in molecular subtypes and provide potential targets for early detection and therapy. To better characterize molecular changes in ESCC, we followed up a previous cDNA array study with additional discovery and confirmatory studies in new ESCC cases using alternative methods. We profiled global gene expression (Affymetrix U133A/B chip) for discovery and confirmation, and validated selected dysregulated genes with additional RNA (qRT-PCR, N=51) or protein studies (immunohistochemistry [IHC] of tumor tissue microarray [TMA], N=275).We also found genes associated with survival. The dysregulated genes should aid in identifying risk factors in ESCC, as well as potential targets for early detection, and outcome prediction and therapy.

2010-09-01 | GSE23400 | GEO

Global gene expression profiling and validation in esophageal squamous cell carcinoma (ESCC)

2010-09-01 | E-GEOD-23400 | biostudies-arrayexpress

CHI-KAT8i5 suppresses ESCC tumor growth through inhibiting KAT8 mediate c-Myc stability

Project description:The integrated analysis of histone modifier enzymes in solid tumor, especially in esophageal squamous cell carcinoma (ESCC) is still inadequate. Here, we investigate the expression levels of histone modifier enzymes in ESCC tissues. Notably, KAT8 is identified as a prognostic and therapeutic biomarker in ESCC. Esophageal tissue-specific deletion of KAT8 mice exhibite less tumor burden after induction of tumorigenesis via 4NQO treatment compared with wild-type mice. Meanwhile, silencing KAT8 significantly suppresses tumor growth in CDX and PDX model. Mechanically, we confirm that KAT8 regulates c-Myc protein stability by directly binding it. Furthermore, we design and screen a specific KAT8 inhibitor (CHI-KAT8i5) that significantly attenuate tumor growth in vitro and in vivo, providing promising potential for clinical application. Thus, our work identify KAT8 could serve as a potential clinically relevant biomarker and therapeutic target in patients with ESCC disease and optimize KAT8 inhibitor is a promising lead candidate for ESCC therapy.

2024-11-27 | GSE282588 | GEO

Epigenomics analysis of ESCC

Project description:We detected DNA methylation of 15 ESCC samples' tumor tissues and their pericarcinomatous tissues to identify the aberrant DNA methylation status in ESCC.

2021-10-28 | GSE121930 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data